Viewing Study NCT05651269


Ignite Creation Date: 2025-12-24 @ 10:55 PM
Ignite Modification Date: 2025-12-25 @ 8:23 PM
Study NCT ID: NCT05651269
Status: UNKNOWN
Last Update Posted: 2022-12-15
First Post: 2022-12-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Milciclib in Combination With Gemcitabine in Advanced NSCLC
Sponsor: Tiziana Life Sciences LTD
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-03-15
Start Date Type: ESTIMATED
Primary Completion Date: 2024-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-06
Completion Date Type: ESTIMATED
First Submit Date: 2022-12-02
First Submit QC Date: None
Study First Post Date: 2022-12-15
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-12-12
Last Update Post Date: 2022-12-15
Last Update Post Date Type: ACTUAL